GEHC Research Development from 2010 to 2026
| GEHC Stock | 79.20 0.02 0.03% |
Research Development | First Reported 2021-03-31 | Previous Quarter 292 M | Current Value 362 M | Quarterly Volatility 51.7 M |
Check GE HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GE HealthCare's main balance sheet or income statement drivers, such as Tax Provision of 646.3 M, Interest Income of 29.8 M or Discontinued Operations of 15.4 M, as well as many indicators such as Price To Sales Ratio of 1.34, Dividend Yield of 0.0012 or PTB Ratio of 2.54. GEHC financial statements analysis is a perfect complement when working with GE HealthCare Valuation or Volatility modules.
GEHC | Research Development | Build AI portfolio with GEHC Stock |
Analyzing GE HealthCare's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing GE HealthCare's current valuation and future prospects.
Latest GE HealthCare's Research Development Growth Pattern
Below is the plot of the Research Development of GE HealthCare Technologies over the last few years. It is GE HealthCare's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GE HealthCare's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
GEHC Research Development Regression Statistics
| Arithmetic Mean | 935,236,134 | |
| Geometric Mean | 921,200,888 | |
| Coefficient Of Variation | 18.99 | |
| Mean Deviation | 149,039,249 | |
| Median | 833,000,000 | |
| Standard Deviation | 177,561,422 | |
| Sample Variance | 31528.1T | |
| Range | 501M | |
| R-Value | 0.76 | |
| Mean Square Error | 14372.5T | |
| R-Squared | 0.57 | |
| Significance | 0.0004 | |
| Slope | 26,608,123 | |
| Total Sum of Squares | 504448.9T |
GEHC Research Development History
About GE HealthCare Financial Statements
GE HealthCare stakeholders use historical fundamental indicators, such as GE HealthCare's Research Development, to determine how well the company is positioned to perform in the future. Although GE HealthCare investors may analyze each financial statement separately, they are all interrelated. For example, changes in GE HealthCare's assets and liabilities are reflected in the revenues and expenses on GE HealthCare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GE HealthCare Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 1.3 B | 1.1 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:Check out the analysis of GE HealthCare Correlation against competitors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Will Health Care Equipment & Supplies sector continue expanding? Could GEHC diversify its offerings? Factors like these will boost the valuation of GE HealthCare. Market participants price GEHC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every GE HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.18) | Dividend Share 0.14 | Earnings Share 4.55 | Revenue Per Share | Quarterly Revenue Growth 0.071 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GE HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.